Compare KB Financial Group, Inc. (KB) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KB Financial Group, Inc. vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? KB Financial Group, Inc. trades at $123.07 (market cap $42.62B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B). The key difference: KB Financial Group, Inc. is far larger — about 18.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and KB Financial Group, Inc. pays a 2.71% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| KB | SLS | |
|---|---|---|
Market Cap | $42.62B | $2.27B |
Volume | 164,291 | 4,179,659 |
Sector | Financials | Health |
52-Week High | $132.88 | $15.46 |
52-Week Low | $77.50 | $1.39 |
Typical Hold Time | 33 Days | — |
Enterprise Value | $215.53T | $2.14B |
Dividend Yield | 2.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KB Financial Group (KB) trades at $123.07, down 1.33% today, with mixed technical signals showing a neutral overall trend. The company demonstrates strong fundamentals with consistent earnings beats, including Q2 2026 EPS of $3.79 beating expectations of $3.51. Revenue growth has been steady from $17.8T in 2022 to $21.2T in 2025, with net income margins improving to 27.47%. Analyst sentiment is mixed with 33% buy ratings and 67% hold recommendations.
KB presents a compelling value opportunity with a P/E of 9.68 and P/B of 0.94 below industry averages. The main investment thesis centers on continued earnings momentum and South Korean market outperformance, though risks include banking sector volatility and interest rate sensitivity. The stock's current valuation discount to intrinsic value suggests potential upside if earnings growth persists.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About KB Financial Group, Inc.
KB Financial is the parent company of KB Kookmin Bank, Korea's largest commercial bank, with a 13.1% share of loans as of 2021. Its predecessor banks were established in the 1960s as government policy banks and privatized in the 1990s. Its credit card subsidiary KB Kookmin Card is the number-three player behind Shinhan Card and Samsung Card. KB has in recent years expanded its nonbank business by buying LIG Insurance and Hyundai Securities, making KB a top-five player in nonlife insurance and in securities, and most recently by buying Prudential Life Insurance Korea. It also has KB Capital, which provides leasing and installment finance.
Read more on KB →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
